(Q33412621)

English

Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

systemic-onset juvenile idiopathic arthritis

0 references

1 reference

based on heuristic

inferred from title

juvenile rheumatoid arthritis

1 reference

based on heuristic

inferred from title

activation syndrome

1 reference

based on heuristic

inferred from title

macrophage activation syndrome

1 reference

based on heuristic

inferred from title

author name string

Vishnu V Reddy

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Arpita Myles

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Satyanaryan S Cheekatla

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sushma Singh

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Amita Aggarwal

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

13 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

International Journal of Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

261-267

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Recognition and management of macrophage activation syndrome in juvenile arthritis

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Macrophage activation syndrome in children with systemic-onset juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Macrophage activation syndrome in juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India.

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Systemic JIA: new developments in the understanding of the pathophysiology and therapy

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Macrophage activation syndrome in a patient with systemic onset rheumatoid arthritis: rescue with intravenous immunoglobulin therapy.

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome.

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12196

21 January 2018

Identifiers

10.1111/1756-185X.12196

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33412621&oldid=1536337153"